Fig. 5
From: DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target
Correlations between DLGAP5 expression and immune infiltration and immune-checkpoint blockades (ICB)-relevant genes in LUAD. A Correlation between DLGAP5 expression and the relative abundances of 24 types of immune cells. B Th2 cell infiltration level in low- and high-DLGAP5 expression groups (***P < 0.001). C Correlation between DLGAP5 expression and Th2 cell infiltration. D Differences in mRNA expression of ICB-relevant genes (PDCD1, CD274, PDCD1LG2, CTLA4, IDO1, LAG3, ICOS, HAVCR2 and TNFRSF4) between high- and low-DLGAP5 groups in TCGA-LUAD cohort (*P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant). E–K Correlation between DLGAP5 expression and ICB-relevant genes of PDCD1 (E), CD274 (F), PDCD1LG2 (G), CTLA-4 (H), IDO1 (I), LAG3 (J) and HAVCR2 (K) in TIMER 2.0 database